← Back to Search

EHR-Based Approach for Reducing Medication Dosing Errors

N/A
Recruiting
Led By H. Shonna Yin, MD, MS
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 4 weeks of index visit (visit 1)
Awards & highlights

Study Summary

This trial will study whether an automated electronic health record (EHR)-based intervention that uses e-prescriptions can improve pharmacy dispensing practices and reduce parent dosing errors. The study will be conducted with English- and Spanish-speaking parents of children who are prescribed oral liquid medications in the pediatric emergency room, outpatient general pediatric clinic, and pediatric subspecialty clinics of 2 New York City hospital systems.

Who is the study for?
This trial is for English or Spanish-speaking parents or guardians over 18 years old, who are the primary caregivers of children aged ≤8 years prescribed liquid medications in specific New York City hospitals. Participants must have a smartphone and be willing to participate. Pharmacists involved must dispense medication to study participants.Check my eligibility
What is being tested?
The trial tests an EHR-based intervention aimed at helping pharmacists stick to mL-only dosing instructions and provide appropriate dosing tools, with the goal of reducing parental dosing errors with children's liquid medicines.See study design
What are the potential side effects?
Since this study focuses on improving dispensing practices rather than testing new medications, it does not directly involve medical side effects. However, there may be indirect effects related to changes in how medicine doses are managed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 4 weeks of index visit (visit 1)
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 4 weeks of index visit (visit 1) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Caregiver Dosing Error
Caregiver Large Dosing Error
Pharmacy Provision of Optimal Dosing Tool
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Post-Implementation - EHR-Based ApproachExperimental Treatment1 Intervention
Group II: Pre-Implementation - Usual CareActive Control1 Intervention
In pre-implementation phase, patient e-Rxs will be generated by the EHR in the usual fashion.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,226 Total Patients Enrolled
Food and Drug Administration (FDA)FED
171 Previous Clinical Trials
1,331,106 Total Patients Enrolled
H. Shonna Yin, MD, MSPrincipal InvestigatorNYU Langone Health
3 Previous Clinical Trials
3,101 Total Patients Enrolled

Media Library

EHR-Based Approach Clinical Trial Eligibility Overview. Trial Name: NCT05146388 — N/A
Medication Dosing Error Research Study Groups: Pre-Implementation - Usual Care, Post-Implementation - EHR-Based Approach
Medication Dosing Error Clinical Trial 2023: EHR-Based Approach Highlights & Side Effects. Trial Name: NCT05146388 — N/A
EHR-Based Approach 2023 Treatment Timeline for Medical Study. Trial Name: NCT05146388 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any further participants being sought for this experiment?

"Affirmative. The clinical trial's information on clinicaltrials.gov confirms that it is actively looking for participants at this time, having first been posted April 21st 2022 and last updated August 22nd 2022. A total of 500 patients need to be sourced from 3 separate study locations."

Answered by AI

How many individuals are currently engaged in this clinical experiment?

"Affirmative. The clinicaltrials.gov website states that this research study, initially posted on April 21st 2022, is currently open for recruitment with 500 participants sought from 3 different locations."

Answered by AI
~56 spots leftby Aug 2024